PT | EN

Version 2-Menu@2x

The Science

The Science

Axenya: founded on science and supported by a comprehensive clinical program
Axenya subjects to the most strict clinical guidelines. Clinical results are regularly presented in world-class medical meetings and published by peer-reviwed

Previous
Next

Patients reach recommended clinical targets

eAG reducted to ADA recommended levels
Estimated Average Glucose – Less is better (mcg/ml)

Fast onset and sustained performance
eA1C vs baseline – Less is better (%)

Kralixya delivers substantial reduction of the risk of complications
and associated healthcare costs

Peer reviewed studies suggest that 1% reduction in A1C, sustained through time, equals to reductions of:

Patients lose weight and significantly improve compliance with doctor’s indications

Peer reviewed studies suggest that 1% reduction in A1C, sustained through time, equals to reductions of:

2% improvement it average weight for overweight (Type) cohort

40% to 53% increased compilance with physician indications 
(SMBG – Times per week)

Kralixya patients improve their habits, get useful feedback,
understand their health better and feel more control over their diabetes

Improve habits

Level of support provided by Kralixya to improve
change in habits for diabetes management (1 to 5).

Feedback

Understanding impact of habits and actions on own health,
compared with before Kralixya (1 to 5)

Learning

Current understanding of own health,
compared to before use of Kralixya (1 to 5)

Feedback

Sense of control over management of Diabetes,
compared to before use of Kralixya (1 to 5)